Registres
Chaque registre avec son nombre de médicaments et quelques-uns d’entre eux.
États-Unis
FDA · 3 médicaments
- Hydroxyprogesterone Caproate1250MG/5ML · solution · Eugia Pharma
- Delalutin125MG/ML (125MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 250MG/ML (250MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · solution · Bristol Myers Squibb
- Hydroxyprogesterone Caproate125MG/ML, 250MG/ML · Injectable · Quad Pharms
Brésil
Anvisa · 1 médicament · Liste historique
Arabie saoudite
SFDA · 1 médicament · Liste historique
Tous les médicaments contenant Hydroxyprogesterone caproate
Tous les registres, page par page. Dosages et conditionnements figurent sur la page de chaque médicament.
3 résultats
| Médicament | Registre | Dosage | Forme | Statut | Titulaire |
|---|---|---|---|---|---|
| Hydroxyprogesterone Caproate | États-Unis | 1250MG/5ML | solution | Non commercialisé | Eugia Pharma |
| Hydroxyprogesterone Caproate | États-Unis | 125MG/ML, 250MG/ML | Injectable | Non commercialisé | Quad Pharms |
| Delalutin | États-Unis | 125MG/ML (125MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 250MG/ML (250MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution | Non commercialisé | Bristol Myers Squibb |
En bref
- Registres
- 3
- Médicaments
- 5
- Laboratoires
- 5